---
$id: https://graph.org.ai/products/commodity/51141514
$type: Product
source: UNSPSC
code: "51141514"
title: "Zonisamide"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Zonisamide

**UNSPSC Code**: 51141514
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent with the molecular formula C8H8N2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 459384H98V, chemically known as 1,2-benzisoxazole-3-methanesulfonamide but generally known as zonisamide, which bears US NIH Compound Identifier 5734. European Medicines Agency schedules Zonisamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00187MIG. The term ZONISAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). World Health Organization schedules zonisamide in its Anatomical Therapeutic Chemical (ATC) Classification. ZONISAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zonisamide under HS 29350090 and SITC 51580. As of Q4 2014, ZONISAMIDE remains the US FDA Preferred Term for this commodity. Zonisamide bears US NLM identifiers UMLS ID C0078844 and NCI Concept Code C47790. SMILES: S(=O)(=O)(N)CC1NOC2C1CCCC2.

